Key facts
- Cerebral’s last known valuation is $4.8B (Dec 2021).
- It has raised $486.4M across 2 recorded rounds; the latest was Early Stage VC ($48.8M) in Mar 2026.
- Notable investors include Gaingels, Liquid 2 Ventures, SoftBank Investment Advisers, City Light Capital, Trousdale Ventures — 32 tracked in total.
- Cerebral has filed 1 Form D with the SEC, most recently Sep 2025 ($25.0M sold to 53 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 32 names
- ·Watchlist + deal alerts for Cerebral
Funding rounds
2 roundsAbout Cerebral
Developer of a comprehensive mental health care platform designed to deliver integrated therapy and medication management across the United States. The company offers access to a nationwide network of licensed clinicians and partnerships with major insurance providers, enabling individuals seeking mental health support to have improved access to high-quality, evidence-based care.
- Sector
- Healthcare
- HQ
- Claymont, DE, United States
- Founded
- 2020
- Employees
- 2,215
- Website
- cerebral.com/
- Ownership
- Privately Held (backing)
Cerebral doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cerebral shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cerebral in its N-PORT filings yet. We sweep new filings monthly.